We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Tests for Diagnosing Syphilis in Newborns

By HospiMedica staff writers
Posted on 25 Jun 2002
A study has demonstrated that two new blood tests can detect either neonatal antibodies to the syphilis bacterium or the DNA of the syphilis organism itself as predictors of central-nervous system infection. More...
The findings were published in the June 6, 2002, issue of The New England Journal of Medicine.

The two tests used in the study, immunoglobin M (IgM) immunoblotting and polymerase chain reaction (PCR) detected all cases of central-nervous-system infection in a group of 148 infants studied. The babies were all born to syphilis-infected mothers.

The tests were developed by researchers at the University of Texas (UT) Southwestern Medical Center (Dallas, USA). They say the tests provide the first valid data on which to base an effective, cost-efficient neonatal treatment regimen for congenital syphilis. A pregnant woman with syphilis has about a 60-80% chance of infecting her fetus. Infants born to mothers with syphilis are traditionally hospitalized for multiple daily injections of penicillin over a 10-day period because physical exams and conventional laboratory tests are unable to detect all cases. The most accurate lab test until now required a three-month incubation period.

Earlier research at UT Southwestern had suggested that congenital syphilis might stimulate a detectable reaction by the newborn's immune system. "We believed we could evaluate this by searching for the presence in neonatal blood of the infant's IgM antibodies,” said Dr. Michael Norgard, UT chairman of microbiology and a co-author of the study. The study confirmed this theory.




Related Links:
Southwestern Medical Center

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.